KKAMG
BMY icon

Kernodle & Katon Asset Management Group’s Bristol-Myers Squibb BMY Stock Holding History

Kernodle & Katon Asset Management Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$16K Hold
303
– – 0.01% 206
2016
Q4 		$18K Hold
303
– – 0.01% 201
2016
Q3 		$16K Sell
303
-302
-50% -$19.4K 0.01% 230
2016
Q2 		$44K Buy
605
+2
+0.3% +$141 0.04% 138
2016
Q1 		$39K Hold
603
– – 0.04% 135
2015
Q4 		$41K Buy
+603
New +$39.8K 0.04% 135

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Kernodle & Katon Asset Management Group's BMY Position: Q1 2017 in Review

Kernodle & Katon Asset Management Group held its Bristol-Myers Squibb (BMY) position steady in Q1 2017 at 303 shares worth $16K. The position accounts for 0.01% of the portfolio, ranked #206.

Kernodle & Katon Asset Management Group first reported a position in BMY in Q4 2015 and has held it in 6 quarters since. The position peaked at $44K in Q2 2016. 1,597 funds tracked by Wall St. Rank hold BMY as of Q1 2017.

  • Kernodle & Katon Asset Management Group held 303 shares of Bristol-Myers Squibb worth $16K as of Q1 2017.
  • Kernodle & Katon Asset Management Group left its Bristol-Myers Squibb share count unchanged in Q1 2017.
  • Bristol-Myers Squibb made up 0.01% of Kernodle & Katon Asset Management Group's portfolio in Q1 2017, its #206 holding.
  • Kernodle & Katon Asset Management Group first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 6 quarters since.
  • Kernodle & Katon Asset Management Group's Bristol-Myers Squibb position peaked at $44K in Q2 2016.
  • 1,597 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2017.

Based on Kernodle & Katon Asset Management Group's 13F filing for Q1 2017, filed 12 May 2017.